Mark E. Boye - Publications

KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis.

Journal: Cancer treatment and research communications

Published: November 14, 2019

A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: September 02, 2017

Bayesian Model Assessment in Joint Modeling of Longitudinal and Survival Data with Applications to Cancer Clinical Trials.

Journal: Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America

Published: February 28, 2017

JMFit: A SAS Macro for Joint Models of Longitudinal and Survival Data.

Journal: Journal of statistical software

Published: September 13, 2016

First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III Trial.

Journal: Clinical lung cancer

Published: July 08, 2015

Responses to discussants of 'Joint modeling of survival and longitudinal non-survival data: current methods and issues. report of the DIA Bayesian joint modeling working group'.

Journal: Statistics in medicine

Published: January 20, 2015

Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 22, 2014

Can bundled payment improve quality and efficiency of care for patients with hip fractures?

Journal: Journal of aging & social policy

Published: October 10, 2014

Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group.

Journal: Statistics in medicine

Published: January 27, 2014

Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials.

Journal: Statistics in medicine

Published: May 20, 2013

Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 06, 2013

Joint modeling of longitudinal outcomes and survival using latent growth modeling approach in a mesothelioma trial.

Journal: Health services & outcomes research methodology

Published: November 25, 2011